PHKA1

phosphorylase kinase regulatory subunit alpha 1, the group of Phosphorylase kinase subunits

Basic information

Region (hg38): X:72578814-72714319

Previous symbols: [ "PHKA" ]

Links

ENSG00000067177NCBI:5255OMIM:311870HGNC:8925Uniprot:P46020AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • glycogen storage disease IXd (Strong), mode of inheritance: XL
  • glycogen storage disease IXd (Strong), mode of inheritance: XL
  • glycogen storage disease IXd (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glycogen storage disease, type IXdXLPharmacogenomic; Musculoskeletal; RenalIndividuals should avoid circumstances such as vigorous exercise as well as certain medications (eg, succinylcholine, statins) due to risk of rhabdomyolysisBiochemical; Musculoskeletal; Renal2252364; 7874115; 9731190; 12825073; 21634085

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PHKA1 gene.

  • Glycogen storage disease IXd (13 variants)
  • not provided (3 variants)
  • Glycogen phosphorylase kinase deficiency (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHKA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
77
clinvar
9
clinvar
86
missense
215
clinvar
8
clinvar
2
clinvar
225
nonsense
11
clinvar
2
clinvar
13
start loss
0
frameshift
4
clinvar
2
clinvar
1
clinvar
7
inframe indel
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
5
clinvar
1
clinvar
6
splice region
13
14
2
29
non coding
20
clinvar
74
clinvar
37
clinvar
131
Total 15 10 238 159 48

Highest pathogenic variant AF is 0.0000269

Variants in PHKA1

This is a list of pathogenic ClinVar variants found in the PHKA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-72578892-T-C Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)915222
X-72578946-A-T Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)915223
X-72579137-C-A Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)368630
X-72579205-T-C Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)912523
X-72579627-T-C Glycogen storage disease IXd Benign (Jan 13, 2018)912524
X-72579699-A-G Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)368631
X-72579727-T-C Glycogen storage disease IXd Conflicting classifications of pathogenicity (Dec 01, 2022)368632
X-72579737-TAC-T Glycogen phosphorylase kinase deficiency Uncertain significance (Jun 14, 2016)368635
X-72579737-T-TAC Glycogen phosphorylase kinase deficiency Benign (Jun 14, 2016)368633
X-72579737-T-TACAC Glycogen phosphorylase kinase deficiency Uncertain significance (Jun 14, 2016)368634
X-72579851-G-A Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)368636
X-72580115-T-C Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)912525
X-72580198-G-A Glycogen storage disease IXd Benign (Jan 13, 2018)912526
X-72580230-G-A Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)913634
X-72580328-T-G Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)368637
X-72580371-CAG-C Glycogen phosphorylase kinase deficiency Benign (Jun 14, 2016)368638
X-72580449-G-A Glycogen storage disease IXd Uncertain significance (Jan 12, 2018)368639
X-72580499-G-A Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)913635
X-72580502-G-T Glycogen storage disease IXd Benign (Jan 12, 2018)913636
X-72580535-A-G Glycogen storage disease IXd Uncertain significance (Jan 13, 2018)368640
X-72580771-T-A Glycogen storage disease IXd Benign (Jan 13, 2018)368641
X-72581005-T-C Glycogen storage disease IXd Benign (Jan 13, 2018)368642
X-72581017-G-A Glycogen storage disease IXd Likely benign (Mar 17, 2022)1948958
X-72581043-C-T Glycogen storage disease IXd Uncertain significance (Aug 17, 2023)465084
X-72581044-G-A Glycogen storage disease IXd Likely benign (Aug 27, 2023)2146517

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PHKA1protein_codingprotein_codingENST00000373542 32135504
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.09e-71.0012571413201257470.000131
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.883634790.7580.00003687976
Missense in Polyphen94151.890.618872513
Synonymous-0.5461771681.050.00001232386
Loss of Function4.332257.40.3830.00000484858

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001890.000160
Ashkenazi Jewish0.0001340.0000992
East Asian0.0003610.000272
Finnish0.0001250.0000924
European (Non-Finnish)0.0001970.000141
Middle Eastern0.0003610.000272
South Asian0.0003180.000196
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin.;
Disease
DISEASE: Glycogen storage disease 9D (GSD9D) [MIM:300559]: A metabolic disorder characterized by slowly progressive, predominantly distal muscle weakness and atrophy. Clinical features include exercise intolerance with early fatigability, pain, cramps and occasionally myoglobinuria. {ECO:0000269|PubMed:12825073}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glucagon signaling pathway - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Glycogen Metabolism;Metabolism of carbohydrates;Metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism (Consensus)

Recessive Scores

pRec
0.190

Intolerance Scores

loftool
0.0318
rvis_EVS
-0.8
rvis_percentile_EVS
12.46

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.759
ghis
0.528

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.184

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Phka1
Phenotype
homeostasis/metabolism phenotype; muscle phenotype;

Gene ontology

Biological process
glycogen metabolic process;generation of precursor metabolites and energy;protein phosphorylation
Cellular component
cytosol;plasma membrane;phosphorylase kinase complex
Molecular function
phosphorylase kinase activity;calmodulin binding